Leerink Partners Resumes Agilent (A) at Outperform
- Record-setting rally pushes on as S&P ends week up 3 percent
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Leerink Partners resumes coverage on Agilent (NYSE: A) with a Outperform rating and a price target of $53.00.
Analyst Puneet Souda commented, "We view Agilent positively and believe that: (1) Agilent is still a solid margin expansion story and mid-single-digit grower in our Life Science Tools (LST) universe after it spun off Keysight (its electronic management business) in FY2014 to become a pure-play LST company; (2) Agilent is focused on delivering 22% adjusted operating margins in FY2017 – up 150bps from FY2016 levels, which we believe it will achieve if not exceed under the leadership of CEO McMullen; (3) Agilent competes aggressively in multiple markets – delivering solid double-digit growth in biopharma (27% of sales) and maintains either the #1 or #2 position across most of its other end-markets including food, environmental, and chemical/energy; and (4) as emerging markets including China continue to post double-digit growth, Agilent is positioned to capitalize given sizable exposure to these geographies."
Shares of Agilent closed at $45.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTIG Starts Mitek Systems (MITK) at Buy
- Finisar (FNSR) PT Raised to $44 at Needham & Company, Estimates Raised Sharply
- Oppenheimer Raises Price Target on CarMax (KMX) to $72 Ahead of 3Q
Create E-mail Alert Related CategoriesAnalyst Comments, New Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!